See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2017_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 707,865,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 11,295,000 |
| 3 | remainder_Assets | 20,093,000 |
| 4 | LiabilitiesCurrent | 78,512,000 |
| 5 | LiabilitiesNoncurrent | 341,356,000 |
| 6 | remainder_Liabilities | 4,453,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 273,596,000 |
| 9 | ResearchAndDevelopmentExpense | 153,893,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 24,951,000 |
| 12 | remainder_NetIncome | -10,292,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 739,253,000 |
| 1 | Liabilities | 424,321,000 |
| 2 | Expenses | 427,489,000 |
| 3 | Revenues | 24,951,000 |
| 4 | StockholdersEquity | 314,932,000 |
| 5 | NetIncome | -412,830,000 |
| 6 | ComprehensiveNetIncome | -412,830,000 |
| 7 | BaseVar | 813,153,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.470 |
| 9 | EconomicCapitalRatio | 1.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
